切换至 "中华医学电子期刊资源库"

中华危重症医学杂志(电子版) ›› 2016, Vol. 09 ›› Issue (03) : 159 -162. doi: 10.3877/cma.j.issn.1674-6880.2016.03.004

所属专题: 文献

论著

重症肺炎患者血清胆碱酯酶含量变化及其与急性病生理学和长期健康评价Ⅱ评分、多器官功能障碍综合征评分的相关性研究
莫新1, 梁艳冰2, 陈志斌2, 李振宇2, 杨冰玉1, 马中富2,()   
  1. 1. 528000 广东佛山,佛山市第三人民医院神经内科
    2. 510080 广东广州,中山大学附属第一医院普内科
  • 收稿日期:2015-11-19 出版日期:2016-06-01
  • 通信作者: 马中富
  • 基金资助:
    广东省佛山市医学类科技攻关项目(2015AB00384)

Correlation of serum cholinesterase and acute physiology and chronic health evaluation Ⅱ score and multiple organ dysfunction syndrome score in patients with severe pneumonia

Xin Mo1, Yanbing Liang2, Zhibin Chen2, Zhenyu Li2, Bingyu Yang1, Zhongfu Ma2,()   

  1. 1. Department of Neurology, the Third People's Hospital of Foshan, Foshan 528000, China
    2. Department of General Internal Medicine, the First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
  • Received:2015-11-19 Published:2016-06-01
  • Corresponding author: Zhongfu Ma
  • About author:
    Corresponding author: Ma Zhongfu, Email:
引用本文:

莫新, 梁艳冰, 陈志斌, 李振宇, 杨冰玉, 马中富. 重症肺炎患者血清胆碱酯酶含量变化及其与急性病生理学和长期健康评价Ⅱ评分、多器官功能障碍综合征评分的相关性研究[J]. 中华危重症医学杂志(电子版), 2016, 09(03): 159-162.

Xin Mo, Yanbing Liang, Zhibin Chen, Zhenyu Li, Bingyu Yang, Zhongfu Ma. Correlation of serum cholinesterase and acute physiology and chronic health evaluation Ⅱ score and multiple organ dysfunction syndrome score in patients with severe pneumonia[J]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2016, 09(03): 159-162.

目的

探讨重症肺炎患者血清胆碱酯酶(S-ChE)含量的变化及其与急性病生理学和长期健康评价Ⅱ(APACHEⅡ)评分、多器官功能障碍综合征(MODS)评分的相关性。

方法

选择重症肺炎患者86例(重症肺炎组),根据住院期间内是否死亡将研究对象分为存活组(46例)和死亡组(40例)。并同期选择普通肺炎患者100例(普通肺炎)及健康体检者124例(对照组)为对照。采集所有病例进入ICU后24 h内S-ChE水平,并计算其APACHEⅡ评分、MODS评分情况。采用Pearson相关分析对S-ChE水平与APACHEⅡ评分、MODS评分进行相关性研究。

结果

重症肺炎患者组的S-ChE含量为(3 679 ± 1 433)U/L,普通肺炎组为(5 142 ± 1 884)U/L,对照组为(8 469 ± 1 377)U/L,重症肺炎组的S-ChE含量明显低于普通肺炎组和对照组(P均<0.05)。重症肺炎患者死亡组的S-ChE含量明显低于存活组[(2 748 ± 826)U/L vs.(4 489 ± 1 360)U/L,t=7.041,P<0.001],而APACHEⅡ评分[(26 ± 5)分vs.(16 ± 5)分,t=8.540,P<0.001]、MODS评分[(8.15 ± 2.49)分vs.(4.35 ± 2.01)分,t=7.832,P<0.001]则分别明显高于存活组。同时,重症肺炎患者S-ChE含量与APACHEⅡ评分(r=-0.437,P<0.05)、MODS评分(r=-0.337,P<0.05)均存在显著负相关。

结论

重症肺炎患者的S-ChE含量明显降低,其高低能反映重症肺炎患者病情的轻重,并与APACHEⅡ评分、MODS评分呈负相关。

Objective

To observe the change of serum cholinesterase (S-ChE) levels in patients with severe pneumonia and its correlativity with acute physiology and chronic health evaluation Ⅱ(APACHE Ⅱ) score and multiple organ dysfunction syndrome (MODS) score.

Methods

A total of 86 patients with severe pneumonia were enrolled in this study as the severe pneumonia group, and divided into the survival group (46 cases) and death group (40 cases). And 100 patients with common pneumonia (common pneumonia group) and 124 people with health examination normal (control group) were served as control. The S-ChE levels were collected and APACHE Ⅱ score and MODS score were calculated after the patients were hospitalized in ICU within 24 hours. The Pearson correlation was used to analyze the association between S-ChE level and APACHE Ⅱ score as well as MODS score.

Results

The S-ChE levels in the severe pneumonia group, common pneumonia group and control group were (3 679 ± 1 433) U/L, (5 142 ± 1 884) U/L, (8 469 ± 1 377) U/L, respectively, and the S-ChE levels in the severe pneumonia group were much lower than those in the common pneumonia group and control group (all P<0.05). Meanwhile, the S-ChE levels in the death group [(2 748 ± 826) U/L vs. (4 489 ± 1 360) U/L, t=7.041, P<0.001] were much lower, whereas the APACHEⅡscores (26 ± 5 vs. 16 ± 5, t=8.540, P<0.001) and MODS scores (8.15 ± 2.49 vs. 4.35 ± 2.01, t=7.832, P<0.001) were higher than those in the survival group. The Pearson correlation showed that the S-ChE levels were negative related with APACHE Ⅱscore (r=-0.437, P<0.05) and MODS score (r=-0.337, P<0.05).

Conclusion

The S-ChE levels in patients with severe pneumonia decrease remarkedly, which can reflect the severity of severe pneumonia and have negative correlation with APACHE Ⅱscore or MODS score.

表1 三组肺炎患者S-ChE含量的比较(±s
表2 重症肺炎患者存活组与死亡组临床资料比较(±s
[1]
Mandell LA, Wunderink RG, Anzueto A, et al.Infectious Diseases Society of American/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adult[J].Clin Infect Dis, 2007 (44 Suppl 2): S27-S72.
[2]
Richard G, Levy H, Laterre PF, et al.CURB-65, PSI, and APACHE II to assess mortality risk in patients with severe sepsis and community acquired pneumonia in PROWESS[J].J Intensive Care Med, 2011, 26 (1): 34-40.
[3]
田金飞,汤彦,向小卫,等.动态APACHE Ⅲ联合MODS评分在ICU临床研究中的应用[J].职业与健康,2011,27(4):370-372.
[4]
中华医学会呼吸病学分会.社区获得性肺炎诊断和治疗指南[J].中华结核和呼吸杂志,2006,29(10):651-655.
[5]
王超,苏强,张淑文,等.多器官功能障碍综合征病情严重度评分系统[J].中国医学科学院学报,2007,29(4):497-500.
[6]
张细江.老年重症社区获得性肺炎患者血清胆碱酯酶的变化及意义[J].中国急救医学,2009,29(12):1081-1083.
[7]
Kanai S, Honda T, Uehara T, et al.Liver function tests In Patients with bacteremia[J].J Clin Lab Anal, 2008,22 (1): 66-69.
[8]
al-Kassab AS, Vijayakumar E.Profile of serum choline-sterase in systemic sepsis syndrome(septic shock) in intensive care unit patients[J].Eur J Clin Chem Clin Biochem, 1995, 33 (1): 11-14.
[9]
Wolkmer P, Lopes ST, Franciscato C, et al.Trypanosoma evansi: cholinesterase activity in acutely infected Wistar rats[J].Exp Parasitol, 2010, 125 (3): 251-255.
[10]
杨青茹,吴焱旻,张敬浩,等.老年重症肺炎血清胆碱酯酶、前白蛋白与预后[J].临床肺科杂志,2012,17(12):2194-2196.
[11]
刘金涛,王绍红,陈若冰.血清胆碱酯酶在危重症感染患者中的变化对其预后的探索[J].中国医学创新,2013,10(26):126-127.
[12]
刘进,王磊.胆碱酯酶对判断全身炎症反应综合征患者预后的价值[J].临床荟萃,2012,27(1):48-49.
[13]
张细江,何宗广.感染性休克患者血清胆碱酯酶的变化及临床意义[J].中国急救复苏与灾害医学杂志,2013,8(1):26-29.
[14]
卑源琪,陆俊国,陶勇,等.血清胆碱酯酶水平对脓毒症患者病情判断意义[J].交通医学,2013,27(6):658-659.
[15]
朱睿瑶,张迪,冯丽芝,等.血乳酸、胆碱脂酶与APACHEⅡ评分在评估危重症患者病情预后中的研究[J].医学研究杂志,2014,43(3):65-67.
[16]
Hsieh BC, Hsiao HY, Cheng TJ, et al. Assays for serum cholinesterase activity by capillary electrophoresis and an amperometric flow injection choline biosensor[J].Anal Chim Acta, 2008, 623 (2): 157-162.
[17]
陈文彬,潘祥林.诊断学[M].第8版.北京:人民卫生出版社,2013:398.
[18]
黄帆,杨静,仲飞,等.大面积脑梗死患者早期血清胆碱酯酶活性检测的临床意义[J].热带医学杂志,2008,8(10):1046-1048.
[19]
郑建琼,黄德斌.老年脓毒症患者血清清蛋白、D-二聚体及胆碱酯酶检测意义[J].中国老年学杂志,2014,34(13):3522-3523.
[20]
李艳华,张国荣,任连峰.多器官功能障碍障碍综合征的血清白蛋白及胆碱酯酶肌钙蛋白T水平的意义和预后的关系[J].河北医学,2013,19(4):490-492.
[21]
施新萍,楼利剑,娄域峰.肺部疾病引发全身炎症反应综合征的老年患者死亡因素分析[J/CD].中华危重症医学杂志:电子版,2011,4(1):26-30.
[1] 段燕, 郭欣, 吕慧芳, 王国利, 黄明光, 董英俊. 乳腺癌患者辅助化疗后感染肺孢子菌一例[J]. 中华乳腺病杂志(电子版), 2023, 17(05): 318-321.
[2] 张巧梅, 孙小平, 李冠胜, 邓扬嘉. 针灸对大鼠呼吸机相关性肺炎中性粒细胞归巢及胞外诱捕网的影响[J]. 中华危重症医学杂志(电子版), 2023, 16(04): 265-271.
[3] 罗晨, 宗开灿, 李世颖, 傅应亚. 微小RNA-199a-3p调控CD4T细胞表达参与肺炎支原体肺炎患儿免疫反应研究[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(05): 569-574.
[4] 杨梅, 周春, 赵艾红, 王琴. 儿童难治性肺炎支原体肺炎所致塑型性支气管炎风险列线图模型的构建[J]. 中华实验和临床感染病杂志(电子版), 2023, 17(04): 274-281.
[5] 胡皓翀, 刘一霆, 郭嘉瑜, 邹寄林, 陈忠宝, 周江桥, 邱涛. 肾移植术后耐碳青霉烯类肺炎克雷伯菌感染的诊疗分析[J]. 中华移植杂志(电子版), 2023, 17(04): 246-249.
[6] 安钱, 徐彬, 陈志祥, 徐晶晶, 黄丹丹. PCT、CRP及SAA对呼吸机相关性肺炎病情严重程度和预后分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 544-546.
[7] 卞天丹, 宋爽, 陶臻. 高毒力肺炎克雷伯菌分子学机制研究进展[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 438-441.
[8] 肖慧, 徐维国, 范小兵, 李厚衡. 血清IL-34、SP-D、CXCL17在甲型流感病毒性肺炎患者中表达及临床意义[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 349-351.
[9] 盛名, 王敬文, 郭爽, 万文蕾. 重症肺炎NT-proBNP动态演变与患者预后风险的相关性分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 379-381.
[10] 尤素伟. 老年脑卒中后吞咽障碍与卒中相关性肺炎的相关性研究[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(03): 150-155.
[11] 陆猛桂, 黄斌, 李秋林, 何媛梅. 蜂蛰伤患者发生多器官功能障碍综合征的危险因素分析[J]. 中华临床医师杂志(电子版), 2023, 17(9): 1010-1015.
[12] 李静静, 翟蕾, 赵海平, 郑波. 多囊肾合并囊肿的多重耐药菌感染一例并文献复习[J]. 中华临床医师杂志(电子版), 2023, 17(08): 920-923.
[13] 余林阳, 王美英, 李建斌, 楼骁斌, 谢思远, 马志忠, 齐海英, 李稼. 高原地区肺炎合并右心功能衰竭体征患儿的肺动脉压力和心脏形态与功能的特征[J]. 中华临床医师杂志(电子版), 2023, 17(05): 535-544.
[14] 于洋, 刘孝洁, 王丽娟, 高宇晨, 丁瑶, 敖虎山. 新冠肺炎常态化条件下心肺复苏培训模式初探[J]. 中华临床医师杂志(电子版), 2023, 17(04): 483-486.
[15] 王燕, 郭蕊, 王淑杰. 老年烧伤气管切开患者死亡风险诊断模型构建及对策分析[J]. 中华诊断学电子杂志, 2023, 11(04): 249-253.
阅读次数
全文


摘要